TP53 and acute myeloid leukemia: Specifically, the KMT2A and TP53m genetic groups have very little overlap with other common AML mutations as reported by others, suggesting that both 11q23/KMT2A rearrangements [40] and TP53 mutations [3] are strong drivers of the disease.